Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS)
NCT04595617
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Glanzmann Thrombasthenia
Interventions
BIOLOGICAL:
Antibodies screening
Sponsor
University Hospital, Bordeaux